slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,281-5,310
Pages 296
Rows per page 30
Slide type
5,281-5,310 of 8,880
17
Uses a Venn diagram to represent the intersection of three properties optimized by AI.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
20
The slide uses a linear process flow to explain the company's core technology platform.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
23
The slide uses a linear process flow that loops back to show the end-to-end integration of biological and computational steps.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
25
The slide uses a linear process flow to demonstrate the platform's capabilities.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
26
The slide illustrates the mechanism of incorporating non-standard amino acids into antibodies for ADC development.Absci | Investor Presentation Deck | 37 slides · Absci
Pitch deck Investor relations 1 hit
05
The slide uses a hub-and-spoke diagram centered on 'Informed by Data, Powered by Technology' to connect various retail and marketing services.Advantage Solutions | Investor Presentation Deck | 27 slides · Advantage Solutions
Pitch deck Investor relations Beat · Solution1 hit
11
Includes a biological process diagram showing intracellular vs plasma metabolism.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
28
The slide uses a process flow diagram to contrast intracellular metabolism with plasma-based enzymatic intervention.Aeglea BioTherapeutics | Investor Presentation Deck | 39 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
08
The slide uses a process-oriented diagram to show how three distinct mechanisms of action (MOAs) combine to lead to a clinical outcome.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Includes a schematic of the GalNAc-linker-RNAi construct and a bar chart illustrating the suppression of various HBV transcripts.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
20
The slide uses a three-column layout to explain the scientific basis and benefits of the drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
22
The slide uses a three-column layout to highlight the core benefits of the product.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
25
The slide maps the viral genome to specific drug targets and highlights partnerships with X-Chem and Proteros.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
26
The slide highlights key therapeutic advantages of the candidate drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution1 hit
04
Uses a hierarchical structure to break down the objective into three strategic pillars.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
10
The slide uses a vertical process flow to demonstrate the progression of clinical validation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
04
The slide uses a value chain framework to show disintermediation or integration of ad-tech services.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a hub-and-spoke style layout to show how these five pillars support the central Azerion brand.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide uses a 'from X to Y' framing to demonstrate the breadth of the platform's utility.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a funnel-like visual structure to map business segments to specific value propositions.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
25
The slide uses a value-chain style architecture diagram to show how the company's platform integrates various demand and supply side components.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
26
Uses a value chain comparison to illustrate market efficiency.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
27
The slide uses a feature-comparison matrix to differentiate service tiers for publishers.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
05
Includes a 'No' list for negative ingredients and a set of certification icons.Celsius Holdings | Investor Presentation Deck | 23 slides · Celsius Holdings
Pitch deck Investor relations 1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) shift the curve to the left compared to 24 hours, indicating higher potency/efficacy with sustained exposure.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
24
Includes a BioRender diagram illustrating the molecular pathway.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
27
Includes molecular structure of ONC206 and protein structures of targets DRD2 and ClpP.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
29
The slide uses in vitro cell viability data and PK modeling to justify a dose intensification strategy.Chimerix | Investor Presentation Deck | 38 slides · Chimerix
Pitch deck Investor relations 1 hit
05
The slide serves as a visual summary of the brand's value proposition and product ecosystem.Hims & Hers | Investor Presentation Deck | 32 slides · Hims & Hers
Pitch deck Investor relations Beat · What Could BeLoop · Cost Of Inaction1 hit
13
The slide uses a three-column layout with icons and descriptive text to explain the platform's value proposition.Hims & Hers | Investor Presentation Deck | 32 slides · Hims & Hers
Pitch deck Investor relations Beat · Solution & Approach1 hit